Table 1.
Overview of the visits and measurements
Follow-up | ||||
Visit Number | 1 | 2 | 3–4–5... | Final visit |
Month | 0 | 3 | 6-month intervals | |
Inclusion/Exclusion criteria | x | |||
Informed Consent | x | |||
Medical history | x | |||
Concomitant Medication | x | x | x | x |
Weight | x | x | x | |
Height | x | |||
Waist circumference | x | x | x | |
Blood pressure/Heart rate | x | x | x | |
HbA1c | x | x | x | |
AST, ALT | x | x | x | |
Creatinine | x | x | x | |
Microlbuminuria | x | x | x | |
Albumin/creatinine ratio | x | x | x | |
Total cholesterol, HDL cholesterol, Triglycerides | x | x | x | x |
Adverse events | x | x | x | |
Compliance | x | x | x | |
End-point verification | x | x | x |